Examorelin
CAS No. 140703-51-1
Examorelin ( Hexarelin )
Catalog No. M22397 CAS No. 140703-51-1
Examorelin is an agonist of growth hormone-releasing factor (GHRF), and for the treatment of cardiac diseases.hexarelin treatment protected cardiac function in the chronic phase as evidenced by higher ejection fraction and fractional shortening, as well as lower lung weight/body weight and lung weight/tibial length ratios, compared with vehicle treatment.?
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 59 | In Stock |
|
5MG | 89 | In Stock |
|
10MG | 149 | In Stock |
|
25MG | 220 | In Stock |
|
50MG | 338 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameExamorelin
-
NoteResearch use only, not for human use.
-
Brief DescriptionExamorelin is an agonist of growth hormone-releasing factor (GHRF), and for the treatment of cardiac diseases.hexarelin treatment protected cardiac function in the chronic phase as evidenced by higher ejection fraction and fractional shortening, as well as lower lung weight/body weight and lung weight/tibial length ratios, compared with vehicle treatment.?
-
DescriptionExamorelin is an agonist of growth hormone-releasing factor (GHRF), and for the treatment of cardiac diseases.hexarelin treatment protected cardiac function in the chronic phase as evidenced by higher ejection fraction and fractional shortening, as well as lower lung weight/body weight and lung weight/tibial length ratios, compared with vehicle treatment.?Hexarelin treatment concurrently lowered plasma epinephrine and dopamine levels, and shifted the balance of autonomic nervous activity toward parasympathetic nervous activity as evidenced by a smaller low/high-frequency power ratio and larger normalized high-frequency power on heart rate variability analysis.
-
SynonymsHexarelin
-
PathwayOthers
-
TargetOther Targets
-
Recptorhormone-releasing factor (GHRF)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number140703-51-1
-
Formula Weight887.06
-
Molecular FormulaC47H58N12O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@H](NC(=O)[C@@H](Cc1c(C)[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yuanjie, Mao, Takeshi, et al. Hexarelin treatment in male ghrelin knockout mice after myocardial infarction.[J]. Endocrinology, 2013.
molnova catalog
related products
-
Fibrinopeptide B, hu...
FibrinopeptideB,human is a 14-amino acid polypeptide released from the amino terminus of the fibrinogen segment.
-
Dodecylphosphocholin...
Dodecylphosphocholine is a substrate-type inhibitor of pancreas phospholipase A2. Dodecylphosphocholine is a detergent.
-
Dodecenylsuccinic an...
Dodecenylsuccinic anhydride can be grafted with collagen hydrogels as a hydrophobic wound dressing to incorporate simvastatin.